Finance

Lists
Why is NAMS down 3,97%?
Dive Deeper
NAMS:NASDAQ
NewAmsterdam Pharma Company NV
23,20 $
-3,97%
(-0,96) 1D
23,64 $
+1,90% (+0,44)
After hours
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMS...
Open
24,60 $
High
24,75 $
Low
22,67 $
Mkt. cap
2,77 մլրդ
Avg. vol.
1,63 մլն
Volume
1,55 մլն
52-wk high
42,20 $
52-wk low
21,02 $
EPS
-2,15 $
Beta
0,10
Shares outstanding
119,54 մլն
No. of employees
100
Open
24,60 $
High
24,75 $
Low
22,67 $
Mkt. cap
2,77 մլրդ
Avg. vol.
1,63 մլն
Volume
1,55 մլն
52-wk high
42,20 $
52-wk low
21,02 $
EPS
-2,15 $
Beta
0,10
Shares outstanding
119,54 մլն
No. of employees
100
News stories
From web sources and news partners
About NewAmsterdam Pharma Company NV
CEO-
Employees100
Founded2019
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to NAMS in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NAMS in the last 3 months.
Highest
Current 23,20 $
60,00 $ (+158,62%)
Average
53,75 $ (+131,68%)
Lowest
48,00 $ (+106,90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
52,00 $
+124,1%
09/29/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
57,00 $
+145,7%
09/22/2026
Conor MacKay
BMO Capital
Buy
Maintained
58,00 $
+150%
09/21/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/18/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
50,00 $
+115,5%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
48,00 $
+106,9%
08/07/2026
Leonid Timashev
RBC Capital
Buy
Maintained
50,00 $
+115,5%
08/05/2026
Unknown Analyst
Citi
Buy
Maintained
55,00 $
+137,1%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
60,00 $
+158,6%
08/04/2026
Evan Seigerman
BMO Capital
Buy
Initiated
58,00 $
+150%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
58,00 $
+150%
07/20/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
45,00 $
+94%
05/07/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/07/2026
Asad Haider
Goldman Sachs
Hold
Maintained
38,00 $
+63,8%
05/07/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
45,00 $
+94%
04/02/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
45,00 $
+94%
04/02/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Reiterated
49,00 $
+111,2%
02/19/2026
Geoff Meacham
Citi
Buy
Maintained
55,00 $
+137,1%
01/30/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
348,00 հզր
32,00 հզր
3,04 մլն
3,70 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
30,97 մլն
38,59 մլն
38,01 մլն
41,67 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24,52 մլն
27,42 մլն
23,45 մլն
26,89 մլն
Operating expense
55,49 մլն
66,01 մլն
61,46 մլն
68,56 մլն
Total operating expenses
55,49 մլն
66,01 մլն
61,46 մլն
68,56 մլն
Operating income
-55,14 մլն
-65,98 մլն
-58,42 մլն
-64,86 մլն
Other non operating income
-23,79 մլն
-15,34 մլն
5,94 մլն
-4,56 մլն
EBT including unusual items
-72,00 մլն
-74,92 մլն
-48,44 մլն
-64,14 մլն
EBT excluding unusual items
-72,00 մլն
-74,92 մլն
-48,44 մլն
-64,14 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-72,00 մլն
-74,92 մլն
-48,44 մլն
-64,14 մլն
Net profit margin
-20 691,09%
-234 134,38%
-1 593,45%
-1 732,91%
Earnings per share
-
-
-
-
Interest and investment income
6,71 մլն
6,47 մլն
5,65 մլն
5,81 մլն
Interest expense
-
-
-
-
Net interest expenses
6,71 մլն
6,47 մլն
5,65 մլն
5,81 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-55,08 մլն
-65,92 մլն
-58,36 մլն
-64,80 մլն
Gain or loss from assets sale
1,00 հզր
11,00 հզր
12,00 հզր
6,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps